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Prostate cancer is an excellent candidate disease for chemo prevention 
because it is typically diagnosed in elderly males, therefore even a modest 
delay in the neoplastic development achieved through pharmacological or 
nutritional intervention could result in a substantial reduction in the 
incidence of this clinically detectable disease. Phytoestrogens are found in 
many plants, which are commonly used, in traditional medicine. These 
compounds may be both agonists and antagonists of estrogen receptors in 
humans. These estrogenic compounds may influence prostate cancer cell growth 
and because of this, herbal therapies have been developed. Oxidative stress 
can greatly impact the development of many diseases including cancer thus it 
is important to understand the regulation of enzymes that protect against 
oxidative stress.  Phase II detoxification enzymes (glutathione S-transferase 
and quinone reductase) many of which are regulated by the ARE, are known to 
protect cells from oxidative stress. Our hypothesis is some phytoestrogens 
and baicalein may up regulate Phase II enzymes as QR and GST which are 
responsible for combating the oxidative stress that is considered as one of 
the key factors for cancer induction. Human prostate cancer cell line (PC-3) 
was treated with six concentrations of baicalein. (0, 5, 10, 15, 25 and 50 
uM) over 3 days. QR enzyme levels were measured in the treated cells and 
compared to the control (untreated) cells. This study will hopefully provide 
evidence to test if phytoestrogens may be working through a QR mechanistic 
pathway to prevent prostate cancer. 
 
